Sinphar Pharmaceutical Co. Ltd. - PE Ratio

The PE Ratio as of July 2026 (TTM) for Sinphar Pharmaceutical Co. Ltd. (1734.TW) is 17.15

According to Sinphar Pharmaceutical Co. Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is 17.15. This represents a change of -4.17% compared to the average of 17.90 of the last 4 quarters.

Sinphar Pharmaceutical Co. Ltd. (1734.TW) Historical PE Ratio (quarterly & annually)

How has 1734.TW PE Ratio performed in the past?

The mean historical PE Ratio of Sinphar Pharmaceutical Co. Ltd. over the last ten years is 61.81. The current 17.15 PE Ratio has changed 2.67% with respect to the historical average. Over the past ten years (40 quarters), 1734.TW's PE Ratio was at its highest in in the March 2021 quarter at 230.42. The PE Ratio was at its lowest in in the June 2018 quarter at -482.75.

Sinphar Pharmaceutical Co. Ltd. (1734.TW) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Sinphar Pharmaceutical Co. Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Sinphar Pharmaceutical Co. Ltd. (1734.TW) Average PE Ratio

How has 1734.TW PE Ratio performed in the past?

The current PE Ratio of Sinphar Pharmaceutical Co. Ltd. (1734.TW) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

Sinphar Pharmaceutical Co. Ltd. (1734.TW) PE Ratio vs. Peers

How is 1734.TW’s PE Ratio compared to its peers?

Sinphar Pharmaceutical Co. Ltd.’s PE Ratio is greater than OBI Pharma, Inc. (-0.98), less than Panion & Bf Biotech Inc. (24.98), less than Savior Lifetec Corp. (26.86), greater than Hi-Clearance Inc. (14.87), less than TaiGen Biopharmaceuticals Holdings Limited (114.27), greater than Pharmosa Biopharm Inc. (-12.46), less than Locus Cell Co., Ltd. (0), greater than Pacific Hospital Supply Co., Ltd (16.63), greater than Mycenax Biotech Inc. (-12.16), greater than BioGend Therapeutics Co., Ltd. (-48.28),

Build a custom stock screener for Sinphar Pharmaceutical Co. Ltd. (1734.TW) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Sinphar Pharmaceutical Co. Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Sinphar Pharmaceutical Co. Ltd. (1734.TW) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Sinphar Pharmaceutical Co. Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.